Gabriele P - Search Results

1

Accessibility as a major determinant of radiotherapy underutilization: a population based study.

Pagano E, Di Cuonzo D, Bona C, Baldi I, Gabriele P, Ricardi U, Rotta P, Bertetto O, Appiano S, Merletti F, Segnan N, Ciccone G. Pagano E, et al. Among authors: gabriele p. Health Policy. 2007 Mar;80(3):483-91. doi: 10.1016/j.healthpol.2006.05.006. Epub 2006 Jun 14. Health Policy. 2007. PMID: 16781002

2

Are quality indicators for radiotherapy useful in the evaluation of service efficacy in a new based radiotherapy institution?

Gabriele P, Malinverni G, Bona C, Manfredi M, Delmastro E, Gatti M, Penduzzu G, Baiotto B, Stasi M. Gabriele P, et al. Tumori. 2006 Nov-Dec;92(6):496-502. doi: 10.1177/030089160609200606. Tumori. 2006. PMID: 17260490

3

[THe cost of radiotherapy. Piedmontese experience].

Gabriele P, Ozzello F, Negri GL, Rotta P, Pasquino M, Sinistrero G. Gabriele P, et al. Radiol Med. 1998 Jun;95(6):656-62. Radiol Med. 1998. PMID: 9717551 Italian.

4

Prospective phase II trial of neoadjuvant chemo-radiotherapy with Oxaliplatin and Capecitabine in locally advanced rectal cancer (XELOXART).

Ricardi U, Racca P, Franco P, Munoz F, Fanchini L, Rondi N, Dongiovanni V, Gabriele P, Cassoni P, Ciuffreda L, Morino M, Filippi AR, Aglietta M, Bertetto O. Ricardi U, et al. Among authors: gabriele p. Med Oncol. 2013;30(2):581. doi: 10.1007/s12032-013-0581-0. Epub 2013 Apr 19. Med Oncol. 2013. PMID: 23606239 Clinical Trial.

5

Radiotherapy alone or with concomitant daily low-dose carboplatin in locally advanced, unresectable head and neck cancer: definitive results of a phase III study with a follow-up period of up to ten years.

Ruo Redda MG, Ragona R, Ricardi U, Beltramo G, Rampino M, Gabriele P, Allis S, La Porta MR, Moro G, Melano A, Gabriele AM, Tessa M, Fossati P, Orecchia R. Ruo Redda MG, et al. Among authors: gabriele am, gabriele p. Tumori. 2010 Mar-Apr;96(2):246-53. doi: 10.1177/030089161009600210. Tumori. 2010. PMID: 20572581 Clinical Trial.

6

Is one Gy always one Gy? The integration between conventional radiotherapy and special techniques.

Gabriele P, Bona C, Piermattei A, Baiotto B. Gabriele P, et al. Rays. 2004 Jul-Sep;29(3):283-5. Rays. 2004. PMID: 15603299

7

Vinorelbine treatment of recurrent salivary gland carcinomas.

Airoldi M, Bumma C, Bertetto O, Gabriele P, Succo G, Pedani F. Airoldi M, et al. Among authors: gabriele p. Bull Cancer. 1998 Oct;85(10):892-4. Bull Cancer. 1998. PMID: 9835866 Free article.

8

Comparison of endorectal magnetic resonance imaging, clinical prognostic factors and nomograms in the local staging of prostate cancer patients treated with radiotherapy.

Cirillo S, Petracchini M, Bona CM, Durando S, Ortega C, Vormola R, Stasi M, Malinverni G, Aglietta M, Regge D, Gabriele P. Cirillo S, et al. Among authors: gabriele p. Tumori. 2008 Jan-Feb;94(1):65-9. doi: 10.1177/030089160809400112. Tumori. 2008. PMID: 18468337

9

Salvage external beam radiotherapy for recurrent prostate adenocarcinoma after high-intensity focused ultrasound as primary treatment.

Munoz F, Guarneri A, Botticella A, Gabriele P, Moretto F, Panaia R, Ruggieri A, D'Urso L, Muto G, Filippi AR, Ragona R, Ricardi U. Munoz F, et al. Among authors: gabriele p. Urol Int. 2013;90(3):288-93. doi: 10.1159/000345631. Epub 2013 Jan 30. Urol Int. 2013. PMID: 23364287

10

Daily low-dose carboplatin and standard radiotherapy in unresectable head and neck and lung cancers: a pilot study.

Orecchia R, Urgesi A, Sacco M, Gabriele P, Vasario E, Ricardi U, Gribaudo S, Sola B, Sannazzari GL. Orecchia R, et al. Among authors: gabriele p. Tumori. 1991 Oct 31;77(5):423-5. doi: 10.1177/030089169107700510. Tumori. 1991. PMID: 1664154

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters